NOVA WELLNESS GROUP BERHAD
KLSE (MYR): NOVA (0201)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.525
Today's Change
0.00 (0.00%)
Day's Change
0.52 - 0.525
Trading Volume
144,400
Financial
Market Cap
Market Cap
167 Million
NOSH
319 Million
Latest Quarter
Latest Quarter
31-Dec-2023 [#2]
Announcement Date
20-Feb-2024
Next Quarter
31-Mar-2024
Est. Ann. Date
23-May-2024
Est. Ann. Due Date
30-May-2024
QoQ | YoY
15.74% | -29.78%
T4Q Result
Revenue | NP to SH
42,187.000 | 12,052.000
RPS | P/RPS
13.24 Cent | 3.97
EPS | P/E | EY
3.78 Cent | 13.88 | 7.20%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.34 | 1.54
QoQ | YoY
-9.57% | -19.0%
NP Margin | ROE
28.69% | 11.12%
F.Y. | Ann. Date
31-Dec-2023 | 20-Feb-2024
Latest Audited Result
Latest Audited Result
30-Jun-2023
Announcement Date
06-Oct-2023
Next Audited Result
30-Jun-2024
Est. Ann. Date
06-Oct-2024
Est. Ann. Due Date
27-Dec-2024
Annual (Unaudited)
Revenue | NP to SH
45,534.000 | 14,926.000
RPS | P/RPS
14.29 Cent | 3.67
EPS | P/E | EY
4.72 Cent | 11.21 | 8.92%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.33 | 1.59
YoY
-6.27%
NP Margin | ROE
32.92% | 14.19%
F.Y. | Ann. Date
30-Jun-2023 | 18-Aug-2023
Annualized Result
Revenue | NP to SH
41,326.000 | 11,422.000
RPS | P/RPS
12.97 Cent | 4.05
EPS | P/E | EY
3.46 Cent | 14.65 | 6.83%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
9.91% | -33.22%
NP Margin | ROE
27.38% | 10.54%
F.Y. | Ann. Date
31-Dec-2023 | 20-Feb-2024
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 0 / 4 | 0.00% | 2 / 8 | 25.00% |
| Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Average ROE | 2.85% | 3.24% | ||
| Average Net Profit Margin | 28.73% | 30.06% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 0 / 5 | 0.00% | 0 / 7 | 0.00% |
| Total Positive Profit Years | 5 / 5 | 100.00% | 7 / 7 | 100.00% |
| Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 7 / 7 | 100.00% |
| Continuous Quarters Of Profit Growth | 0 / 5 | 0.00% | 0 / 7 | 0.00% |
| Continuous Quarters Of Adjusted EPS Growth | 0 / 5 | 0.00% | 0 / 7 | 0.00% |
| Total Dividend Years | 4 / 5 | 80.00% | 4 / 7 | 57.14% |
| Continuous Quarters Of Dividend | 0 / 5 | 0.00% | 0 / 7 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 7 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 7 | 0.00% |
| Average ROE | 14.93% | 967.06% | ||
| Average Net Profit Margin | 35.22% | 37.82% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 42,187 | 41,326 | 45,534 | 35,564 | 39,822 |
| NP to SH | 12,052 | 11,422 | 14,926 | 13,052 | 13,871 |
| Dividend | 0 | 0 | 0 | 2,768 | 3,876 |
| Adjusted EPS | 3.78 | 3.46 | 4.72 | 4.10 | 4.36 |
| Adjusted DPS | 0.00 | 0.00 | 0.00 | 0.87 | 1.22 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | -2.17% | -14.87% | -13.94% | -3.12% | -7.93% |
| NP to Owner | 15.74% | -29.78% | -33.22% | -0.20% | -10.68% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | 17.07% | -28.54% | -35.53% | 1.01% | -9.33% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -7.35% | 5.94% | 18.62% | -9.24% | 3.78% | 16.20% | -7.33% | 14.34% | 28.03% |
| NP to Owner | -19.25% | -13.11% | -7.66% | -23.48% | -17.66% | -12.49% | -6.27% | 7.61% | 14.36% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | -19.92% | -13.29% | -7.81% | -26.69% | -20.63% | -15.62% | -5.53% | 8.27% | 15.11% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
Be the first to like this. Showing 50 of 833 comments
On behalf of the Board, Kenanga IB wishes to inform that Bursa Securities had, vide its letter dated 19 January 2021, approved the Transfer under the “Health Care” sector.
The Transfer will take effect immediately two (2) market days upon the announcement to Bursa Securities on the transfer date via Bursa Link.
This announcement is dated 20 January 2021.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3122541
2021-01-21 08:36
so there's another announcement, and then have to wait for 2 days then only transfer to main board?
2021-02-07 15:28
Only Sinovac vaccine approved by NPRA and Pharmaniaga allowed to distribute not Nova Un Well.
Posted by donkeycharles > Jan 29, 2021 1:56 PM | Report Abuse
any news on hepar p clinical trials?
2021-03-02 23:15
Bursa is not strict enough such that many conmen successful con many ikan bilis.
2021-03-02 23:31
Shareholders just go to tiih for instance to view signed contracts and photos of signing also cannot meh?
2021-03-02 23:35
Once third trial test on hepar passes after a few years, it will add much value to Nova.
2021-05-09 20:55
Anyone knows Nova's new plant latest news? Is it already commissioning or still in construction?
2021-09-10 00:56
The Board of Directors of Nova Wellness Group Berhad wishes to announce the positive results from the recently completed Hepar-P clinical trial to assess its efficacy and safety in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
2021-11-09 21:11
Yesterday 22/11 saw Nova's truck running on Kepong road. Haha good sign to continue hold it
2021-11-23 01:04
Lapsap company should change to FMCG sector not healthcare, selling roti and jam
2023-12-05 11:58
Post a Comment
Featured Posts
New Update. Discover investment communities that resonate with your ideas
One App To Trade Malaysia & US Stock With 0* Commission
MQ Trading Signals
Time
Signal
Duration
Type
2024-04-25 16:55:00
EMA 5
5 Mins
BUY
2024-04-25 16:50:00
EMA 5
10 Mins
BUY
2024-04-25 16:50:00
ADX
10 Mins
BUY
2024-04-25 16:50:00
ADX
5 Mins
BUY
2024-04-25 16:40:00
EMA 5
10 Mins
SELL
Apps
Top Articles
1
Good Articles to Share
Malaysia in Talks With Tycoons on Casino to Revive $100 Billion Forest City
2
3
4
5
BFM Podcast
6
BFM Podcast
7
BFM Podcast
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
donkeycharles
when are they going to main board?
2020-12-29 17:16